ASX - By Stock
|
PER |
Re:
Let’s go
|
|
SottoVoce
|
92 |
35K |
16 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
92
|
35K
|
16
|
|
ASX - By Stock
|
PER |
Re:
Reject Name Change Resolution
|
|
SottoVoce
|
43 |
13K |
3 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
43
|
13K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Let’s go
|
|
SottoVoce
|
92 |
35K |
7 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
92
|
35K
|
7
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
SottoVoce
|
3.5K |
1.0M |
16 |
31/12/23 |
31/12/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
16
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
SottoVoce
|
3.5K |
1.0M |
5 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
SottoVoce
|
3.5K |
1.0M |
11 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
11
|
|
ASX - By Stock
|
PER |
Re:
Ann: Annual General Meeting Presentation
|
|
SottoVoce
|
81 |
22K |
7 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
81
|
22K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Reject Name Change Resolution
|
|
SottoVoce
|
43 |
13K |
7 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
43
|
13K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Reject Name Change Resolution
|
|
SottoVoce
|
43 |
13K |
7 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
43
|
13K
|
7
|
|
ASX - By Stock
|
PER |
Reject Name Change Resolution
|
|
SottoVoce
|
43 |
13K |
13 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
43
|
13K
|
13
|
|
ASX - By Stock
|
PER |
Re:
CG options strike price 6.1 cents
|
|
SottoVoce
|
25 |
6.1K |
0 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
25
|
6.1K
|
0
|
|
ASX - By Stock
|
PER |
Re:
CG options strike price 6.1 cents
|
|
SottoVoce
|
25 |
6.1K |
0 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
25
|
6.1K
|
0
|
|
ASX - By Stock
|
PER |
Re:
CG options strike price 6.1 cents
|
|
SottoVoce
|
25 |
6.1K |
7 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
25
|
6.1K
|
7
|
|
ASX - By Stock
|
PER |
Re:
CG options strike price 6.1 cents
|
|
SottoVoce
|
25 |
6.1K |
7 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
25
|
6.1K
|
7
|
|
ASX - By Stock
|
PER |
CG options strike price 6.1 cents
|
|
SottoVoce
|
25 |
6.1K |
29 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
25
|
6.1K
|
29
|
|
ASX - By Stock
|
PER |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
SottoVoce
|
45 |
12K |
5 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
45
|
12K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
SottoVoce
|
45 |
12K |
5 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
45
|
12K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
SottoVoce
|
45 |
12K |
11 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
45
|
12K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
SottoVoce
|
4.3K |
3.8M |
7 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
4.3K
|
3.8M
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
SottoVoce
|
4.3K |
3.8M |
0 |
21/03/22 |
21/03/22 |
ASX - By Stock
|
4.3K
|
3.8M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
SottoVoce
|
4.3K |
3.8M |
5 |
21/03/22 |
21/03/22 |
ASX - By Stock
|
4.3K
|
3.8M
|
5
|
|
ASX - By Stock
|
PAR |
Re:
PATENT REJECTED BUT PAR SILENT
|
|
SottoVoce
|
12 |
6.5K |
0 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
12
|
6.5K
|
0
|
|
ASX - By Stock
|
PAR |
PATENT REJECTED BUT PAR SILENT
|
|
SottoVoce
|
12 |
6.5K |
3 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
12
|
6.5K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm patent rejection
|
|
SottoVoce
|
87 |
30K |
3 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
87
|
30K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm patent rejection
|
|
SottoVoce
|
87 |
30K |
2 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
87
|
30K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm patent rejection
|
|
SottoVoce
|
87 |
30K |
3 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
87
|
30K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm patent rejection
|
|
SottoVoce
|
87 |
30K |
1 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
87
|
30K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm patent rejection
|
|
SottoVoce
|
87 |
30K |
4 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
87
|
30K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Why are people selling?
|
|
SottoVoce
|
41 |
15K |
4 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
41
|
15K
|
4
|
|
ASX - By Stock
|
PAR |
Why are people selling?
|
|
SottoVoce
|
41 |
15K |
23 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
41
|
15K
|
23
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
SottoVoce
|
339 |
140K |
15 |
26/01/22 |
26/01/22 |
ASX - By Stock
|
339
|
140K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
Big pharma deal incoming.
|
|
SottoVoce
|
39 |
17K |
6 |
17/01/22 |
17/01/22 |
ASX - By Stock
|
39
|
17K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
SottoVoce
|
339 |
140K |
6 |
17/01/22 |
17/01/22 |
ASX - By Stock
|
339
|
140K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM TREATS FIRST SUBJECTS IN PHASE 3 TRIAL OF ZILOSUL
|
|
SottoVoce
|
42 |
17K |
3 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
42
|
17K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
SottoVoce
|
4.3K |
3.8M |
6 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
4.3K
|
3.8M
|
6
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
SottoVoce
|
339 |
140K |
11 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
339
|
140K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
SottoVoce
|
339 |
140K |
11 |
13/12/21 |
13/12/21 |
ASX - By Stock
|
339
|
140K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
PAR and the Deal, what do we need?
|
|
SottoVoce
|
16 |
8.1K |
22 |
12/12/21 |
12/12/21 |
ASX - By Stock
|
16
|
8.1K
|
22
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
SottoVoce
|
339 |
140K |
7 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
339
|
140K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
PAR Investor Meeting - Questions from HC
|
|
SottoVoce
|
122 |
40K |
11 |
05/12/21 |
05/12/21 |
ASX - By Stock
|
122
|
40K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
SottoVoce
|
4.4K |
2.0M |
4 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
The Microcap Advantage.
|
|
SottoVoce
|
8 |
3.3K |
10 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
8
|
3.3K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
SottoVoce
|
4.3K |
3.8M |
3 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
4.3K
|
3.8M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
SottoVoce
|
4.3K |
3.8M |
1 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
4.3K
|
3.8M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
SottoVoce
|
4.3K |
3.8M |
3 |
16/10/21 |
16/10/21 |
ASX - By Stock
|
4.3K
|
3.8M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
SottoVoce
|
4.3K |
3.8M |
9 |
15/10/21 |
15/10/21 |
ASX - By Stock
|
4.3K
|
3.8M
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS
|
|
SottoVoce
|
80 |
28K |
5 |
13/10/21 |
13/10/21 |
ASX - By Stock
|
80
|
28K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM REPORTS IND APPLICATION UPDATE
|
|
SottoVoce
|
150 |
61K |
8 |
04/09/21 |
04/09/21 |
ASX - By Stock
|
150
|
61K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM REPORTS IND APPLICATION UPDATE
|
|
SottoVoce
|
150 |
61K |
1 |
04/09/21 |
04/09/21 |
ASX - By Stock
|
150
|
61K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM REPORTS IND APPLICATION UPDATE
|
|
SottoVoce
|
150 |
61K |
1 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
150
|
61K
|
1
|
|